CONTEXTVISION AB (CONTX.OL) Stock Price & Overview

OSL:CONTXSE0014731154

Current stock price

3.14 NOK
+0.02 (+0.64%)
Last:

The current stock price of CONTX.OL is 3.14 NOK. Today CONTX.OL is up by 0.64%. In the past month the price decreased by -2.18%. In the past year, price decreased by -46.78%.

CONTX.OL Key Statistics

52-Week Range2.7 - 6.35
Current CONTX.OL stock price positioned within its 52-week range.
1-Month Range2.7 - 3.7
Current CONTX.OL stock price positioned within its 1-month range.
Market Cap
242.942M
P/E
314.00
Fwd P/E
29.45
EPS (TTM)
0.01
Dividend Yield
4.18%

CONTX.OL Stock Performance

Today
+0.64%
1 Week
+4.67%
1 Month
-2.18%
3 Months
-25.24%
Longer-term
6 Months -27.98%
1 Year -46.78%
2 Years -53.82%
3 Years -64.48%
5 Years -84.46%
10 Years N/A

CONTX.OL Stock Chart

CONTEXTVISION AB / CONTX Daily stock chart

CONTX.OL Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to CONTX.OL. When comparing the yearly performance of all stocks, CONTX.OL is a bad performer in the overall market: 94.87% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CONTX.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL. CONTX.OL has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CONTX.OL Earnings

Next Earnings DateMay 8, 2026
Last Earnings DateFeb 19, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

CONTX.OL Forecast & Estimates

7 analysts have analysed CONTX.OL and the average price target is 4.08 NOK. This implies a price increase of 29.94% is expected in the next year compared to the current price of 3.14.

For the next year, analysts expect an EPS growth of 1100% and a revenue growth 7.55% for CONTX.OL


Analysts
Analysts40
Price Target4.08 (29.94%)
EPS Next Y1100%
Revenue Next Year7.55%

CONTX.OL Groups

Sector & Classification

Index Membership

CONTX.OL Financial Highlights

Over the last trailing twelve months CONTX.OL reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS decreased by -96.77% compared to the year before.


Income Statements
Revenue(TTM)110.28M
Net Income(TTM)762.00K
Industry RankSector Rank
PM (TTM) 0.69%
ROA 0.61%
ROE 0.83%
Debt/Equity 0.1
Chartmill High Growth Momentum
EPS Q2Q%-42.87%
Sales Q2Q%-7.27%
EPS 1Y (TTM)-96.77%
Revenue 1Y (TTM)-15.61%

CONTX.OL Ownership

Ownership
Inst Owners6.92%
Shares77.37M
Float26.38M
Ins Owners24%
Short Float %N/A
Short RatioN/A

About CONTX.OL

Company Profile

CONTX logo image ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 44 full-time employees. The firm is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The firm develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVision’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The firm operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.

Company Info

IPO: 1997-03-06

CONTEXTVISION AB

Hollandargatan 13, 2 tr

Stockholm STOCKHOLM SE

Employees: 44

CONTX Company Website

CONTX Investor Relations

Phone: 4687503550

CONTEXTVISION AB / CONTX.OL FAQ

What does CONTEXTVISION AB do?

ContextVision AB operates as a medical technology software company that specializes in image analysis and artificial intelligence. The company is headquartered in Stockholm, Stockholm and currently employs 44 full-time employees. The firm is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The firm develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVision’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The firm operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.


What is the current price of CONTX stock?

The current stock price of CONTX.OL is 3.14 NOK. The price increased by 0.64% in the last trading session.


Does CONTX stock pay dividends?

CONTEXTVISION AB (CONTX.OL) has a dividend yield of 4.18%. The yearly dividend amount is currently 0.


What is the ChartMill technical and fundamental rating of CONTX stock?

CONTX.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Would investing in CONTEXTVISION AB be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CONTX.OL.


What is the market capitalization of CONTX stock?

CONTEXTVISION AB (CONTX.OL) has a market capitalization of 242.94M NOK. This makes CONTX.OL a Micro Cap stock.